William Ashton

Insider Reports History

Entity
Individual
Location
C/O Harrison Consulting Group, Po Box 283, Newtown Square, PA
Signature
/s/ James Quinlan, as Attorney-in-Fact, for William L. Ashton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Ashton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Baudax Bio, Inc. Director Common Stock 42.5K $108K $2.55 Jun 15, 2022 Direct
Societal CDMO, Inc. Director Common Stock 0 $0 $1.10 Apr 8, 2024 Direct
Medicus Pharma Ltd. Director Common Shares, no par value ("Common Shares") 1.25K Dec 31, 2024 Direct
Societal CDMO, Inc. Director Stock Option (Right to Buy) 0 Apr 8, 2024 Direct
SPECTRUM PHARMACEUTICALS INC Director Common Stock, $0.001 par value 0 $1.10 Jul 31, 2023 Direct
SPECTRUM PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 Jul 31, 2023 Direct

Insider Reports Filed by William Ashton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MDCX Medicus Pharma Ltd. Dec 31, 2024 0 $0 3 Dec 31, 2024 Director
SCTL Societal CDMO, Inc. Apr 8, 2024 4 -$290K 4 Apr 8, 2024 Director
SCTL Societal CDMO, Inc. Aug 28, 2023 1 $10.1K 4 Aug 28, 2023 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jul 31, 2023 2 $0 4 Aug 1, 2023 Director
SCTL Societal CDMO, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
SPPI SPECTRUM PHARMACEUTICALS INC Aug 31, 2022 2 $0 4 Sep 2, 2022 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jun 21, 2022 1 -$3.36K 4 Jun 22, 2022 Director
BXRX Baudax Bio, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
SCTL Societal CDMO, Inc. May 18, 2022 2 $0 4 May 20, 2022 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jun 17, 2021 3 -$38.2K 4 Jun 22, 2021 Director
SCTL Recro Pharma, Inc. Apr 20, 2021 1 $0 4/A May 17, 2021 Director